Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Snape

Showing results (121-130 of 169) with videos related to

Pageof 17
Sort By:
The Journal of Infectious Diseases|August 15, 2020
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in EuropeJoanne G Wildenbeest, Roy P Zuurbier, Koos Korsten, et al.
Nature Communications|October 8, 2021
Publisher Correction: Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virusGu-Lung Lin, Simon B Drysdale, Matthew D Snape, et al.
Nature Communications|August 27, 2021
Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virusGu-Lung Lin, Simon B Drysdale, Matthew D Snape, et al.
The Lancet. Infectious Diseases|January 12, 2015
Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trialMildred A Iro, Ameneh Khatami, Andrew S J Marshall, et al.
The Lancet. Respiratory Medicine|November 13, 2022
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort studyJoanne G Wildenbeest, Marie-Noëlle Billard, Roy P Zuurbier, et al.
Archives of Disease in Childhood|September 28, 2022
Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trialsOwen Martyn Bendor-Samuel, Tabitha Wishlade, Louise Willis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on studyWoolf T Walker, Philip de Whalley, Nick Andrews, et al.
The Pediatric Infectious Disease Journal|December 15, 2010
Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trialMatthew D Snape, Chaam L Klinger, Elvis D Daniels, et al.
Nature Communications|March 17, 2024
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virusGu-Lung Lin, Simon B Drysdale, Matthew D Snape, et al.
Medicine|January 9, 2015
A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccineMainga Hamaluba, Rama Kandasamy, Susan Ndimah, et al.
Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
The Journal of Infectious Diseases|August 15, 2020
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in EuropeJoanne G Wildenbeest, Roy P Zuurbier, Koos Korsten, et al.
Nature Communications|October 8, 2021
Publisher Correction: Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virusGu-Lung Lin, Simon B Drysdale, Matthew D Snape, et al.
Nature Communications|August 27, 2021
Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virusGu-Lung Lin, Simon B Drysdale, Matthew D Snape, et al.
The Lancet. Infectious Diseases|January 12, 2015
Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trialMildred A Iro, Ameneh Khatami, Andrew S J Marshall, et al.
The Lancet. Respiratory Medicine|November 13, 2022
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort studyJoanne G Wildenbeest, Marie-Noëlle Billard, Roy P Zuurbier, et al.
Archives of Disease in Childhood|September 28, 2022
Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trialsOwen Martyn Bendor-Samuel, Tabitha Wishlade, Louise Willis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on studyWoolf T Walker, Philip de Whalley, Nick Andrews, et al.
The Pediatric Infectious Disease Journal|December 15, 2010
Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trialMatthew D Snape, Chaam L Klinger, Elvis D Daniels, et al.
Nature Communications|March 17, 2024
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virusGu-Lung Lin, Simon B Drysdale, Matthew D Snape, et al.
Medicine|January 9, 2015
A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccineMainga Hamaluba, Rama Kandasamy, Susan Ndimah, et al.
Pageof 17